Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 211-220 of 222 for multiple myeloma

Edit search filters
  1. Appointment Companion Tool

    Rochester, MN

  2. Financial Difficulty in Patients With Blood Cancer

    Scottsdale/Phoenix, AZ

  3. A Study to Evaluate Gut Microbiome with POEMS Syndrome and Other Plasma Cell Disorders

    Rochester, MN

  4. Symptomatic Assessment in Patients with Chronic Hematologic Malignancies

    Scottsdale/Phoenix, AZ

  5. Global Cardio Oncology Registry

    Rochester, MN

  6. A Study to Evaluate the Safety, PK/​PD of (OriCAR-017) in Subjects With RR/​MM - RIGEL Study

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. Low-Dose Selinexor and Choline Salicylate for the Treatment of Patients With Non-Hodgkin Lymphoma or Histiocytic/Dendritic Cell Neoplasms

    Rochester, MN

  8. cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR)

    Rochester, MN

  9. Mayo Clinic Cancer Genomics Service Line Biorepository

    Eau Claire, WI, Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. A Study of the Natural History of Monoclonal Gammopathy of Undetermined Significance (MGUS) Over Time

    Rochester, MN

.

Mayo Clinic Footer